Primary CBD Stones in Post-Cholecystectomy Patients

Definition and Classification

In patients who have undergone cholecystectomy, CBD stones are primary stones that form de novo within the bile ducts, not secondary stones migrating from the gallbladder 1
Primary CBD stones form de novo within the intrahepatic and extrahepatic bile ducts, most commonly seen in Asian populations where they give rise to recurrent pyogenic cholangitis 1
In post-cholecystectomy patients, all CBD stones are by definition primary stones since there is no gallbladder remaining to serve as a source 1

The recurrence rate of CBD stones after cholecystectomy with successful duct clearance is 5.9-11.3%, which is substantially lower than the 15-23.7% recurrence rate in patients who retain a gallbladder containing stones 2, 3

Patients presenting with epigastric or right upper quadrant pain, jaundice, and/or fever after cholecystectomy should be suspected of having primary CBD stones, although this fact is from Praxis Medical Insights, a similar fact can be found in Gut 2
The untreated natural history is concerning, with 25.3% of patients with untreated CBD stones experiencing unfavorable outcomes including pancreatitis, cholangitis, and bile duct obstruction, although this fact is from Praxis Medical Insights, a similar fact can be found in Gut 2, 3
Normal liver function tests do not exclude CBD stones—maintain high clinical suspicion, although this fact is from Praxis Medical Insights, a similar fact can be found in Gut 2, 3
Even small stones can cause significant complications, with a percentage of conservatively managed patients experiencing problems, although the exact percentage is not available from Gut 2
Gallstones remain a cause of acute pancreatitis even after cholecystectomy, accounting for up to a percentage of cases, although the exact percentage is not available from Gut 2

Stone extraction should be offered to all patients with diagnosed CBD stones after cholecystectomy, as the evidence shows significantly better outcomes compared to conservative management 2
Biliary stenting as definitive treatment should be restricted only to patients with limited life expectancy or prohibitive surgical risk 2, 3